Modification of the Early Gene Enhancer-promoter Improves the Oncolytic Potency of Adenovirus 11

Oncolytic adenoviruses based on serotype 5 (Ad5) have several shortcomings, including the downregulation of its receptor in cancer cells, high prevalence of neutralizing antibodies and hepatotoxicity. Another adenoviral serotype, Ad11, could overcome these obstacles. Here, we show that human cancer...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Wong, Han Hsi, Jiang, Guozhong, Gangeswaran, Rathi, Wang, Pengju, Wang, Jiwei, Yuan, Ming, Wang, Hexiao, Bhakta, Vipul, Müller, Heike, Lemoine, Nicholas R, Wang, Yaohe
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 2012
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3272483/
https://ncbi.nlm.nih.gov/pubmed/22086234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.242
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים